StockData
Q32 Bio Inc. logo

Q32 Bio Inc. (QTTB) stock

QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$8.53−0.10 (-1.16%)

Close on Nov 18, 2026Market cap $253.93MP/E –Yield –

Q32 Bio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Q32 Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$19.83M. For fiscal 2025 it was -$33.54M. The highest annual figure on record is $6.48M in fiscal 2017.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$33.54M–
FY2024Dec 31, 2024-$67.72M–
FY2023Dec 31, 2023-$18.68M–
FY2022Dec 31, 2022-$113.66M–
FY2021Dec 31, 2021-$109.75M–
FY2020Dec 31, 2020-$94.33M–
FY2019Dec 31, 2019-$91.36M–
FY2018Dec 31, 2018-$42.56M-756.9%
FY2017Dec 31, 2017$6.48M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.08M–
Q1 FY2026Mar 31, 2026-$6.34M–
Q4 FY2025Dec 31, 2025-$6.18M–
Q3 FY2025Sep 30, 2025-$4.23M–
Q2 FY2025Jun 30, 2025-$10.65M–
Q1 FY2025Mar 31, 2025-$12.48M–
Q4 FY2024Dec 31, 2024-$11.43M–
Q3 FY2024Sep 30, 2024-$19.52M-222.8%
Q2 FY2024Jun 30, 2024-$22.21M–
Q1 FY2024Mar 31, 2024-$14.55M–
Q4 FY2023Dec 31, 2023-$10.72M–
Q3 FY2023Sep 30, 2023$15.90M–
Q2 FY2023Jun 30, 2023-$11.37M–
Q1 FY2023Mar 31, 2023-$12.50M–
Q4 FY2022Dec 31, 2022-$27.20M–
Q3 FY2022Sep 30, 2022-$24.93M–
Q2 FY2022Jun 30, 2022-$30.85M–
Q1 FY2022Mar 31, 2022-$30.68M–
Q4 FY2021Dec 31, 2021-$30.43M–
Q3 FY2021Sep 30, 2021-$25.39M–
Q2 FY2021Jun 30, 2021-$24.11M–
Q1 FY2021Mar 31, 2021-$29.82M–
Q4 FY2020Dec 31, 2020-$11.61M–
Q3 FY2020Sep 30, 2020-$28.89M–
Q2 FY2020Jun 30, 2020-$27.99M–
Q1 FY2020Mar 31, 2020-$25.85M–
Q4 FY2019Dec 31, 2019-$26.33M–
Q3 FY2019Sep 30, 2019-$25.48M–
Q2 FY2019Jun 30, 2019-$21.67M–
Q1 FY2019Mar 31, 2019-$17.87M–
Q4 FY2018Dec 31, 2018-$8.08M-136.6%
Q3 FY2018Sep 30, 2018-$13.69M–
Q2 FY2018Jun 30, 2018-$9.75M–
Q1 FY2018Mar 31, 2018-$11.04M–
Q4 FY2017Dec 31, 2017$22.05M–
Q3 FY2017Sep 30, 2017-$5.45M–
Q2 FY2017Jun 30, 2017-$5.60M–
Q1 FY2017Mar 31, 2017-$4.52M–

More Q32 Bio figures

See a number that looks wrong?